bLegionella londiniensis has been isolated from aqueous environments. However, to our knowledge, this organism has never been isolated from clinical specimens. A case of Legionnaires' disease in a hematopoietic stem cell transplant recipient caused by this organism is described, which confirms that L. londiniensis can be an opportunistic pathogen.
CASE REPORTA 57-year-old female presented to a primary care clinic in Charlotte, NC, with fever, chills, and a productive cough of thick green-brown sputum for 2 days' duration, for which she was prescribed ciprofloxacin. She left for vacation in South Carolina, where she experienced worsening sputum production, increased shortness of breath, and a fever of 38.3°C. Her oxygen saturation was noted as 72% on 2 liters of oxygen/min. One day later, she was taken to a local emergency department for further evaluation.Her medical history was significant for chronic lymphocytic leukemia (status, postmyeloablative), a sibling allogeneic bone marrow transplant 7 months prior, cytomegalovirus pneumonia, Pneumocystis jirovecii pneumonia, and parainfluenza respiratory viral infection 5 months prior, which left her oxygen dependent. Current medications included acyclovir, voriconazole, atovaquone, and long-term prednisone therapy.On physical examination, the patient was febrile at 38.5°C, tachycardic at 123 beats per minute, and tachypneic at 30 breaths per minute. She was hypoxic, with oxygen saturation of 78% on room air. Auscultation of the lungs revealed coarse breath sounds. Pitting edema (grade 2 to 3ϩ) was present in the lower extremities. Hematologic studies revealed a white blood cell count of 2,620/mm 3 , hemoglobin of 9.1 g/dl, hematocrit of 27.8%, and a platelet count of 43,000/mm 3 . Results of comprehensive metabolic panel tests were all within normal limits. Computed tomography of the chest revealed extensive consolidation within the left upper lobe and patchy consolidation in the left lower lobe. A small left pleural effusion and mediastinal lymphadenopathy were also present. The patient was intubated and admitted to the intensive care unit. She was empirically treated for pneumonia in an immunocompromised host with cefepime, linezolid, azithromycin, and trimethoprim/sulfamethoxazole.The following tests were obtained: respiratory virus panel PCR (xTAG RVP; Luminex, Austin, TX), a procalcitonin test (Vidas BRAHMS; bioMérieux, Durham, NC), a serum cryptococcal antigen test, aerobic and anaerobic bacterial blood cultures, a Legionella urinary antigen test (Binax/Alere, Waltham, MA), a cytomegalovirus plasma viral load, a urine culture, and sputum cultures for bacteria, acid-fast bacilli, and fungi. The respiratory virus panel was positive for parainfluenza virus type 3. The procalcitonin test result was 6.34 ng/ml. The urine culture was positive for Esherichia coli at greater than 100,000 colonies/ml. All other tests were negative. Due to the severity of her symptoms, the patient underwent bronchoalveolar lavage (BAL), and the sample was sent for cytologic examination ...